SARS-CoV-2 vaccination status and adverse events among patients with psoriasis-Data from the German Registries PsoBest and CoronaBest
J Eur Acad Dermatol Venereol
.
2023 Jul;37(7):e831-e833.
doi: 10.1111/jdv.19039.
Epub 2023 Mar 27.
Authors
María José Valencia López
1
,
Anna Meineke
1
,
Brigitte Stephan
1
,
Stephan Jeff Rustenbach
1
,
Anne Kis
1
,
Diamant Thaçi
2
,
Ulrich Mrowietz
3
,
Kristian Reich
1
,
Petra Staubach-Renz
4
,
Ralph von Kiedrowski
5
,
Henriette Bogena
1
,
Matthias Augustin
1
Affiliations
1
Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
2
Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
3
Psoriasis Center Kiel, Department of Dermatology, Venereology and Allergology University Medical Center Schleswig-Holstein, Kiel, Germany.
4
Department of Dermatology and Allergy, University Medical Center Mainz, Mainz, Germany.
5
Dermatological Practice Selters, Selters, Germany.
PMID:
36914370
DOI:
10.1111/jdv.19039
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Psoriasis*
Registries
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines